Smith Sean Michael
Insider CIK 1914769 · NLTX Principal Accounting Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NLTX Neoleukin Therapeutics, In | S Sale | 2023-08-11 | 2023-08-14 | 1,323 | $0.62 | $820 | 21,637 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | M Exercise deriv | 2023-08-10 | 2023-08-14 | 5,000 | — | $0 | 0 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | M Exercise | 2023-08-10 | 2023-08-14 | 5,000 | — | $0 | 22,960 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2023-02-02 | 2023-02-03 | 3,316 | $0.60 | $2.0K | 15,960 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | M Exercise deriv | 2023-02-01 | 2023-02-03 | 12,500 | — | $0 | 12,500 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | M Exercise | 2023-02-01 | 2023-02-03 | 12,500 | — | $0 | 19,276 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | M Exercise deriv | 2022-08-10 | 2022-08-12 | 5,000 | — | $0 | 5,000 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | M Exercise | 2022-08-10 | 2022-08-12 | 5,000 | — | $0 | 8,431 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2022-08-10 | 2022-08-12 | 1,655 | $0.99 | $1.6K | 6,776 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | A Award deriv | 2022-08-02 | 2022-08-04 | 150,000 | — | $0 | 150,000 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | A Award deriv | 2022-03-02 | 2022-03-03 | 80,000 | — | $0 | 80,000 | SEC↗ |